Gyroscope Therapeutics Holdings plc – NASDAQ:VISN

Gyroscope Therapeutics Holdings key metrics

Market Cap
 N/A
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 N/A
Revenue
 N/A
EBITDA
 N/A
Income
 N/A
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Gyroscope Therapeutics Holdings stock price history

Gyroscope Therapeutics Holdings stock forecast

Gyroscope Therapeutics Holdings financial statements

Gyroscope Therapeutics Holdings alternative data

Gyroscope Therapeutics Holdings
Employees

Gyroscope Therapeutics Holdings plc (NASDAQ:VISN): Employee count
Aug 2023 167
Sep 2023 167
Oct 2023 167
Nov 2023 167
Dec 2023 167
Jan 2024 167
Feb 2024 167
Mar 2024 167
Apr 2024 167
May 2024 167
Jun 2024 167
Jul 2024 167

Gyroscope Therapeutics Holdings other data

Frequently Asked Questions (FAQ)

  • When is Gyroscope Therapeutics Holdings's next earnings date?

    Unfortunately, Gyroscope Therapeutics Holdings's (VISN) next earnings date is currently unknown.

  • Does Gyroscope Therapeutics Holdings pay dividends?

    No, Gyroscope Therapeutics Holdings does not pay dividends.

  • What is Gyroscope Therapeutics Holdings's stock symbol?

    Gyroscope Therapeutics Holdings plc is traded on the NASDAQ under the ticker symbol "VISN".

  • What is Gyroscope Therapeutics Holdings's primary industry?

    Company operates in the Healthcare sector and Advertising Agencies industry.

  • How do i buy shares of Gyroscope Therapeutics Holdings?

    Shares of Gyroscope Therapeutics Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Gyroscope Therapeutics Holdings have?

    As Jul 2024, Gyroscope Therapeutics Holdings employs 167 workers.

  • When Gyroscope Therapeutics Holdings went public?

    Gyroscope Therapeutics Holdings plc is publicly traded company for more then 4 years since IPO on 7 May 2021.

  • What is Gyroscope Therapeutics Holdings's official website?

    The official website for Gyroscope Therapeutics Holdings is gyroscopetx.com.

  • How can i contact Gyroscope Therapeutics Holdings?

    Gyroscope Therapeutics Holdings can be reached via phone at +44 1438 906770.

Gyroscope Therapeutics Holdings company profile:

Gyroscope Therapeutics Holdings plc

gyroscopetx.com
Exchange:

NASDAQ

Full time employees:

167

Industry:

Advertising Agencies

Sector:

Healthcare

Gyroscope Therapeutics Holdings plc, a clinical-stage gene therapy company, through its subsidiaries, develops gene therapy products to treat patients with eye diseases. It focuses on developing a pipeline of recombinant adeno-associated virus vector-based gene therapy candidates targeting genetic variants in the complement pathway for age-related macular degeneration. The company is developing GT005, which is in Phase II clinical trials for the treatment of geographic atrophy secondary to age-related macular degeneration; and GT011, a preclinical recombinant adeno-associated virus gene therapy, for the treatment of geographic atrophy secondary to age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom.

+44 1438 906770
Stevenage Bioscience Catalyst
Stevenage,

CIK: 0001837620
ISIN: US40382N1037
CUSIP: 40382N103